Ocular toxocariasis is a presentation of Toxocara infection in which larval migration involves the eye. Managing this form of the disease is more challenging than visceral disease and is directed at preventing progressive damage to ocular structures.
The patient has ocular larva migrans — Toxocara larvae affecting the eye. Treatment strategy is shaped by whether the disease is currently active or in a quiescent phase.
For active disease, systemic antiparasitic therapy may be beneficial, with inflammation management in the eye as an additional consideration — the complete regimen and further intervention options are detailed in the full protocol.
Treatment of ocular toxocariasis is more difficult and usually consists of measures to prevent progressive damage to the eye.
For ocular toxocariasis, the goal of treatment is to minimize damage to the eye.
Systemic antiparasitic treatment with albendazole or mebendazole at the same doses as for visceral disease may be beneficial for active disease.
Control of inflammation in the eye by use of topical or systemic steroids may be indicated.
View source ↗